Cage Pharmaceuticals
Baltimore, US · Founded 2017 · Delaware corporation · 1 known investors
Founders & leadership
JR
Jason RifkinExecutive
Investors · 1
Reported raises · per SEC filings
Form D private placements$967.5K disclosed across 3 rounds · 2017–2024
▶$137.5KraisedMay 2024 · 2 investors · Other Health CareRule 506(b)
▶$137.5KraisedMay 2024 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter OlagunjuExecutive Officer, Director
- Brian MalikDirector
- Nick PapadopoulosDirector
- Isaac RoDirector
- Offering amount
- $137.5K
- Amount sold
- $137.5K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$480KraisedJul 2019 · 1 investors · Other Health CareRule 506(b)
▶$480KraisedJul 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason RifkinExecutive Officer
- Offering amount
- $480K
- Amount sold
- $480K
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$350KraisedJan 2018 · 1 investors · Other Health CareRule 506(b)
▶$350KraisedJan 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason RifkinExecutive Officer
- Offering amount
- $1.7M
- Amount sold
- $350K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Cage Pharmaceuticals's investors?
- Cage Pharmaceuticals's investors include Catalio Capital Management, LP.
- How much funding has Cage Pharmaceuticals raised?
- Cage Pharmaceuticals has disclosed $967.5K raised across 3 rounds.
- Where is Cage Pharmaceuticals headquartered?
- Cage Pharmaceuticals is headquartered in Baltimore, US.